Sanofi and Clayton Dubilier & Rice (CD&R) are in exclusive negotiations for a partial takeover of Sanofi's subsidiary Opella, following the French government's agreement to buy a 2% stake. The deal aims to protect jobs in France and maintain Opella's headquarters and R&D activities there, with a planned investment of €70m over five years. The announcement has sparked backlash in France due to concerns over job security and medicine shortages, especially after the Covid-19 pandemic. Sanofi will retain significant control over Opella, which has an enterprise value of €16bn. Teljes cikk (Euronews.com)